Atherosclerosis and related cardiovascular disorders remain the leading global cause of
morbidity and mortality. Modified low density lipoprotein (LDL) is considered to play a crucial …

Neutrophil extracellular traps (NETs) significantly contribute to various pathophysiological
conditions, including cardiovascular diseases. NET formation in the vasculature exhibits …

Dysregulation of plasma lipids is associated with age‐related cardiovascular diseases. L5,
the most electronegative subfraction of chromatographically resolved low‐density …

Sialylation is a dynamically regulated modification, which commonly occurs at the terminal of
glycan chains in glycoproteins and glycolipids in eukaryotic cells. Sialylation plays a key role …

Low‐density lipoprotein (LDL) is heterogeneous, composed of particles with variable
atherogenicity. Electronegative L5 LDL exhibits atherogenic properties in vitro and in vivo …

Dysregulation of glucose and lipid metabolism increases plasma levels of lipoproteins and
triglycerides, resulting in vascular endothelial damage. Remarkably, the oxidation of lipid …

Abstract Objective Electronegative LDL (LDL (−)) is involved in atherosclerosis through the
activation of the TLR4/CD14 inflammatory pathway in monocytes. Matrix metalloproteinases …

Protein- mediated enamel mineralization Page 1 1220 Modified low-density lipoproteins as
biomarkers in diabetes and metabolic syndrome Andrea Rivas-Urbina1,2, Sonia Benitez1 …

Cardiovascular disease (CVD) is a health problem of great concern to both the public and
medical authorities. Low-density lipoprotein (LDL) has been reported to play an important …

Electronegative L5 low-density lipoprotein (LDL) level may be a useful biomarker for
predicting cardiovascular disease. We determined the range of plasma L5 levels in healthy …